Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19)
Hongyan Li(Hebei Medical University), Yang Zheng(University of Michigan), Chaoying Liu(Electric Power University), Nanya Wang(Jilin University), Yuchen Pan(China Pharmaceutical University), Ling Qin(Central South University), Lina Gu(Jilin University), Hailong You(Jilin University), Jie Cao(University of Science and Technology of China), Pujun Gao(Jilin University), Hongmei Qiao(Jilin University), Nan Li(The University of Texas MD Anderson Cancer Center), Peng Zhang(Zhejiang Hospital), Dan Li(Shanghai Jiao Tong University), Yang Li(Shanghai Jiao Tong University), Heyuan Wang(Jilin University), Songbai Xu(First Hospital of Jilin University), Junqi Niu(Jilin University), Weiying Guo(Jilin University), Menghan Gao(Jilin University)
Cited by 34
Related Papers
Immunogenicity of a DNA vaccine candidate for COVID-19
|Nature Communications|2020|641
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
|Nucleic Acids Research|2017|551
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
|Nucleic Acids Research|2011|485